Viyash Scientific Ltd

Viyash Scientific Ltd

Viyash Scientific Ltd announced unaudited financial results for Q1 FY 2026-2027, with the Board approving the results along with Independent Auditor's Limited Review Report. The company also approved the allotment of equity shares to employees under the Viyash Scientific Limited Employee Stock Option Scheme, 2026, and the incorporation of a wholly owned subsidiary in Vietnam. Additionally, the Board approved the subscription of equity shares in Alivira Animal Health Limited, a wholly owned subsidiary, through Rights Issue.

Viyash Scientific Ltd

Viyash Scientific Ltd has scheduled a conference call on August 12, 2026, to discuss its Q1FY27 earnings/financial results.

Viyash Scientific Ltd

Viyash Scientific Ltd has scheduled a Board Meeting on August 11, 2026, to consider and approve the Unaudited Standalone and Consolidated Financial Results for Q1 FY 2026-27.

Viyash Scientific Ltd

Viyash Scientific Ltd has approved the allotment of 20,01,336 equity shares under the Employee Stock Option Plan 2020 at an exercise price of Rs. 86 per share. The issued and paid-up equity share capital will increase from Rs. 87,37,50,954 to Rs. 87,77,53,626.

Viyash Scientific Ltd

Viyash Scientific Ltd has executed a Sale and Purchase Agreement with the shareholders of BioForLife Italia S.r.l. for the acquisition of 100% of its issued and outstanding share capital for approximately EUR 16.976 million, subject to adjustment for the net financial position.